+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Etomidate"

Local Anesthesia Drugs Market Report 2025 - Product Thumbnail Image

Local Anesthesia Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
  • 10 Results (Page 1 of 1)
Loading Indicator

Etomidate is an intravenous anesthetic drug used for induction of general anesthesia. It is a short-acting, non-barbiturate hypnotic agent that produces rapid onset of anesthesia with minimal cardiovascular and respiratory depression. It is commonly used for short surgical procedures, such as endoscopy, and is also used for rapid sequence intubation. Etomidate is metabolized by the liver and excreted by the kidneys, and has a relatively short duration of action. Etomidate is one of several anesthetic drugs used in the market, which also includes barbiturates, benzodiazepines, and propofol. It is often used in combination with other drugs to provide a balanced anesthetic effect. Etomidate is generally considered to be a safe and effective anesthetic drug, with few side effects. Some companies in the Etomidate market include Hospira, Mylan, Fresenius Kabi, and Teva Pharmaceuticals. Show Less Read more